Prostate cancer screening
Content provided by Healthwise
Prostate cancer screening
Screening for prostate cancer—checking for signs of the disease when there are no symptoms—is done with the digital rectal exam and the prostate-specific antigen (PSA) test. In the United States, about 75% of men who are age 50 or older have had a PSA test.1
The number of deaths caused by prostate cancer has dropped over the past 20 years. The decrease has been linked to more early diagnosis with PSA testing and to better cancer treatment.2
Finding prostate cancer early leads you to some big decisions. Most prostate cancer grows slowly. And the side effects of treatment can change your quality of life—mainly not being able to have an erection (impotence) and not being able to control urination (incontinence). If you are around age 70 or older, these side effects may seem worse than early-stage cancer that may not grow much during your lifetime. But, especially for men 65 or younger, treatment makes the cancer less likely to grow and spread.3
The decision to have a PSA test for prostate cancer depends on your doctor's opinion and your own preferences. Some men will not want to live with the side effects of treatment; other men are more concerned about survival. It is important to learn all you can and talk to your doctor before making a decision.
After reviewing all of the research, the U.S. Preventive Services Task Force (USPSTF) has not recommended for or against routine screening for prostate cancer using the PSA test or digital rectal exam.4
For more information, see the topic Prostate Cancer.
References
Citations
Punglia RS, et al. (2003). Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. New England Journal of Medicine, 349(4): 335–342.
American Cancer Society (2006). Cancer Facts and Figures 2006, pp. 1–56. Atlanta: American Cancer Society. Available online: http://www.cancer.org/docroot/STT/stt_0.asp.
Bill–Axelson A, et al. (2005). Radical prostatectomy versus watchful waiting in early prostate cancer. New England Journal of Medicine, 352(19): 1977–1984.
U.S. Preventive Services Task Force (2003). Screening for prostate cancer: Recommendations and rationale. American Family Physician, 67(4): 787–792.
Credits
| Author | Kathe Gallagher, MSW |
| Author | Ralph Poore |
| Editor | Kathleen M. Ariss, MS |
| Editor | Renée Spengler, RN, BSN |
| Associate Editor | Michele Cronen |
| Associate Editor | Terrina Vail |
| Primary Medical Reviewer | Martin Gabica, MD - Family Medicine |
| Primary Medical Reviewer | Kathleen Romito, MD - Family Medicine |
| Specialist Medical Reviewer | Christopher G. Wood, MD, FACS - Urology/Oncology |
| Last Updated | July 24, 2006 |
| Last updated: | July 24, 2006 |
|---|---|
| Author: | Ralph Poore |
| Reviewed By: | Kathleen Romito, MD - Family Medicine, Christopher G. Wood, MD, FACS - Urology/Oncology |
| Editors: | Renée Spengler, RN, BSN, Terrina Vail |
© 1995-2007, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.
Search
Where Does it Hurt?
If you're experiencing aches and pains we can help you find answers. Find out what your symptoms mean for your health.
